Radiopharmaceuticals are increasingly central to modern diagnostic imaging and targeted therapy. These agents contain radioactive isotopes that emit detectable radiation, enabling visualisation of physiological and molecular processes. Technetium-99m remains one of the most widely used isotopes in SPECT imaging, supporting cardiac, pulmonary and oncological assessment. Fluorine-18 fluorodeoxyglucose underpins PET imaging by highlighting tissues with high glucose metabolism, transforming cancer detection and staging. Gallium-68–labelled compounds allow precise localisation of neuroendocrine tumours, while therapeutic agents such as lutetium-177–based treatments and radium-223 deliver targeted radiation to malignant tissue. Iodine-131 continues to play a key role in the management of thyroid disease. Ongoing research is expanding this field, advancing precision diagnosis and personalised treatment strategies in contemporary healthcare.
home » radiopharmacy »
By
Iodine-131 Iobenguane (I-131 MIBG), a radiopharmaceutical agent, enables early diagnosis and targeted treatment of neuroendocrine tumours, improving patient outcomes.
By
Iodine-131 human serum albumin offers versatile diagnostic and therapeutic applications, despite limitations like radiation exposure and a short half-life.
By
Indium-111 pentetreotide excels in detecting and localising neuroendocrine tumors, monitoring treatment, and identifying therapy candidates.
By
Fluorine-18 Fluoroestradiol PET imaging enables early breast cancer detection, accurate staging, and treatment response monitoring, improving patient outcomes.
By
Iodine-125 iothalamate, with high albumin affinity, ensures accurate GFR measurement, minimal radiation exposure, stability, and cost-effectiveness in diagnostics.
By
Iodine-125 Human Serum Albumin effectively measures blood volume, assesses vascular permeability, and evaluates protein-losing gastroenteropathy for accurate diagnosis.
By
Iodine-123 Sodium Iodide capsules aid in diagnosing thyroid disorders, providing vital insights into thyroid function and structure.
By
Iodine-123 Ioflupane known as DaTscan aids in diagnosing Parkinson’s disease by visualising dopamine transporters using SPECT imaging.
By
Iodine-123 iobenguane is vital for detecting, staging, and monitoring neuroendocrine tumours, guiding treatment, and offering prognostic insights.
By
Indium-111 Pentetate enables tumour detection, infection, inflammation tracking, and cerebrospinal fluid leak identification.
By
Indium-111 oxyquinoline enables diverse cellular imaging, crucial for detecting infections, thrombosis, tumours, and advancing stem cell research.
By
Indium-111 chloride effectively aids infection and inflammation imaging by labelling WBCs, enabling precise issue localisation and severity assessment.
By
Gallium-68 Gozetotide enhances PET imaging for oncology, targeting somatostatin receptors, and offering improved tumour detection and patient care.
By
Gallium-68 DOTATOC revolutionises neuroendocrine tumor diagnosis, enhancing PET imaging accuracy, sensitivity, and management in the medical field.
By
Gallium-68 DOTATATE, a radiopharmaceutical, targets somatostatin receptors, aiding neuroendocrine tumor detection through PET imaging, enhancing diagnostic accuracy and patient outcomes.
By
Gallium-67 citrate is a radiopharmaceutical used for imaging infections, inflammation, cancer, and fever of unknown origin.
By
Fluorine-18 Flutemetamol, a radioactive tracer, for early detection of Alzheimer’s disease through PET imaging, enhancing diagnostic accuracy.
By
Fluorine-18 Fludeoxyglucose, a radiotracer used in PET scans, enables precise cancer diagnosis, evaluating metabolic activity, and monitoring treatment efficacy non-invasively.
By
Fluorine-18 Sodium Fluoride (18F-NaF) is an effective, safe diagnostic radiopharmaceutical, revolutionising bone imaging and detecting skeletal abnormalities with high accuracy.
By
Fluorine-18 Piflufolastat, a novel radiotracer, enables precise imaging of prostate cancer, enhancing diagnostic accuracy and facilitating personalied, targeted treatment approaches.
By
Fluorine-18 Flucicovine (Axumin) improves prostate cancer detection, enabling accurate diagnosis and targeted treatments with PET imaging.
By
Fluorine-18 Flortaucipir: selective tau-binding radiotracer, Alzheimer’s diagnosis, PET imaging, regional limitations, off-target binding, combined diagnostic approach.
By
Fluorine-18 Florbetapir, radiotracer, amyloid plaques, Alzheimer’s disease, PET imaging, early diagnosis, pharmaceutical research, neurodegenerative disorders, brain.
By
Fluorine-18 Florbetaben is a radiotracer used in medical imaging to detect amyloid plaques in the brain.
By
Copper-64 DOTATE, a diagnostic radiopharmaceutical, effectively targets neuroendocrine tumours, enabling precise imaging and personalised treatment plans for cancer patients.
By
Carbon-14 urea, utilised in breath tests, effectively detects Helicobacter pylori infections, aiding gastric ulcer diagnosis and management.
By
Carbon-14 Choline, a radioactive isotope, improves medical imaging accuracy and expands molecular research, aiding cancer diagnosis and treatment.
